HSIC
Henry Schein, Inc.Healthcare · $9.7B market cap
Verdict
Share price
$84.88
close of Oct 3, 2026
Fair value
$80.24
Sticker Price
Payback Price
$32.09
buy price
HSIC is Fairly Valued: at $84.88 it's within 6% of its fair value of $80.24. Its buy price (Payback Price) is $32.09, 62% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.
How we valued it
Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow HSIC
Get notified when it reaches its buy price of $32.09. Free.
Create a free accountSuperinvestors
2 of the investors we track hold HSIC. In Q2 2026, 1 sold out. Who we track
Richard Pzena
Pzena Investment Management · as of Q2 2026
$71.9M
860,733 shares
Mason Hawkins
Southeastern Asset Management · as of Q2 2026
$1.4M
17,038 shares
Moves in Q2 2026
Sold out: First Pacific Advisors
Insider activity
Since Jun 12, 2026: no open-market purchases and 3 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution…
Medical - Distribution
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works